ArticleIJID regions2025
Tuberculosis as a significant cause of uveitis-related blindness: current referral trends at a tertiary uveitis center in Indonesia.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Uveitis may lead to blindness if improperly treated, yet the data on blindness due to uveitis, particularly, in low-resource countries, remain limited. In high-tuberculosis (TB) burden countries such as Indonesia, active systemic TB is among the leading causes of infectious uveitis. The combined impact of blindness, uveitis, and TB presents a substantial health and socioeconomic burden. This study aimed to assess the current situation of uveitis referrals, particularly, on the proportion of uveitis with active systemic TB and the proportion of blindness in TB-related uveitis. Methods: We retrospectively analyzed 1-year data from 164 newly referred patients with uveitis at a single tertiary eye Hospital in Indonesia. Results: Active systemic TB was diagnosed in approximately one in 10 patients with uveitis (16 of 164, 9.8%). At initial presentation, blindness in the worse-seeing eye was noted in 56.1% (92 of 164) of patients. The proportion of blindness was slightly higher in patients with uveitis with active systemic TB and those with no identifiable cause but positive Quantiferon-TB Gold Plus, compared with other uveitis cases, although not statistically significant (56.3%, 61.1%, and 51.3%, respectively; Conclusions: Active TB case finding in patients with uveitis, especially in high-TB burden settings, is obligatory to prevent severe morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.